Geron Corporation (GERN) Q2 2026 Earnings Call Transcript

Geron (GERN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate o

Geron NASDAQ: GERN reported second-quarter net revenue of $57.5 million, up 17% from a year earlier

Achieved $57.5 million in RYTELO ® (imetelstat) net product revenue in Q2 2026, an increase of 11% c

Geron (NASDAQ: GERN - Get Free Report) is projected to issue its Q2 2026 results before the market o

FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercia

FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercia

CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, a biotechnology company

FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercia

Mr. Rath brings senior leadership experience in business development across a range of biopharmaceut

Geron Corporation delivered Q1'26 Rytelo revenues of $51.8M, up 8% sequentially, with two consecutiv

FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercia

Geron Corporation (GERN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Tra

Geron (GERN) has become technically an oversold stock now, which implies exhaustion of the heavy sel

FOSTER CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercia

Geron has secured FDA approval for RYTELO in low- to intermediate-1 risk MDS, marking a pivotal mile

Geron (GERN) has become technically an oversold stock now, which implies exhaustion of the heavy sel

FOSTER CITY, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Investigator-sponsored study, conducted at the Moffitt Cancer Center, demonstrates safety and effica

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

Upgrades

  Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its fir

  Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar

  Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc

Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday afte

Gainers Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) shares jumped 98.40% to $2.5201 after the

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018